NCT06602817

Brief Summary

I-gel Plus is a novel supraglottic airway device that has been evaluated in various studies with high success and low complication rates. Feasibility of supraglottic airway devices (SGA) in patients undergoing surgery in prone position has been demonstrated in some pilot studies and case series; however, the evidence is still limited. It is currently uncertain, if the i-gel Plus facilitates appropriate ventilation in individuals undergoing elective surgery in prone position. The primary aim of this single-center non-inferior study is to assess the leak fraction of the i-gel Plus in patients undergoing surgery in prone position and to compare it with data from an existing prospective control cohort in patients undergoing surgery in supine position. Secondary aims are to investigate the oropharyngeal seal pressure and other secondary outcome parameters and to compare them with the control cohort.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 16, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
12 days until next milestone

Study Start

First participant enrolled

October 1, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 4, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 4, 2025

Completed
Last Updated

June 8, 2025

Status Verified

June 1, 2025

Enrollment Period

4 months

First QC Date

September 16, 2024

Last Update Submit

June 4, 2025

Conditions

Keywords

Prone positionSurgeryAirway management

Outcome Measures

Primary Outcomes (1)

  • Leak fraction

    Ventilation parameter - Leakage volume per tidal volume

    3 hours

Secondary Outcomes (18)

  • Oropharyngeal seal pressure [cm H2O]

    3 hours

  • Leakage volume (ml)

    3 hours

  • Tidal volume (ml)

    3 hours

  • Inspiratory peak pressure (cm H2O)

    3 hours

  • Positive endexpiratory pressure (PEEP) (cm H2O)

    3 hours

  • +13 more secondary outcomes

Study Arms (2)

Surgery in prone position

Patients undergoing elective surgery in prone position with i-gel Plus used for airway management

Other: Exposure: prone position

Surgery in supine position

Existing prospective control cohort with patients undergoing elective surgery in supine position with i-gel Plus used for airway management

Other: Exposure: Supine position

Interventions

Exposure: surgery in prone position

Surgery in prone position

Exposure: Surgery in supine position

Surgery in supine position

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients undergoing elective surgery in prone position with i-gel Plus used for airway management

You may qualify if:

  • Patients scheduling for elective surgery in prone position
  • Planned airway management using a SGA
  • Adult patients (age 18-89 years)
  • ASA physical status 1-3

You may not qualify if:

  • Pregnant or breastfeeding women
  • Non-fasted patients
  • Increased risk of aspiration or other contraindications for supraglottic mask ventilation
  • Shared airway or intracavity open surgery
  • Body mass index (BMI) \>35 kg/m2
  • Inability to understand or sign informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Medical-Center Hamburg Eppendorf

Hamburg, Hamburg, 20246, Germany

Location

Study Officials

  • Martin Petzoldt, MD

    University Medical Center Hamburg-Eppendorf: Universitatsklinikum Hamburg-Eppendorf

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 16, 2024

First Posted

September 19, 2024

Study Start

October 1, 2024

Primary Completion

February 4, 2025

Study Completion

February 4, 2025

Last Updated

June 8, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations